Bengaluru, India

Sharmistha Pal

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharmistha Pal. Retrieved from https://idiyas.com/inventor/sharmistha-pal-4ol01wfa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sharmistha Pal: Innovator in Pharmaceutical Formulations

Introduction

Sharmistha Pal is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing the performance of amorphous solids and solubilized formulations.

Latest Patents

Sharmistha Pal holds a patent for "Enhanced performance of amorphous solid and solubilized formulations for achieving therapeutic plasma concentrations." This invention relates to solid amorphous Compound (I) having a specific formula and to solid amorphous dispersions comprising Compound (I) and one or more polymers. Additionally, it includes solution formulations comprising Compound (I) and one or more co-solvents and surfactants. The formulations exhibit enhanced stability and bioavailability, which are crucial for effective therapeutic applications. He has 1 patent to his name.

Career Highlights

Sharmistha Pal is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations to enhance patient outcomes.

Collaborations

One of his notable coworkers is Robert J Garmise, with whom he collaborates on various projects within the company.

Conclusion

Sharmistha Pal's contributions to pharmaceutical formulations demonstrate his commitment to advancing healthcare through innovation. His work in enhancing the stability and bioavailability of drug formulations is paving the way for more effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…